233 related articles for article (PubMed ID: 18500561)
21. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
22. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
23. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
24. Multiparticulate drug delivery system of aceclofenac: development and in vitro studies.
Shavi GV; Nayak U; Averineni RK; Arumugam K; Meka SR; Nayanabhirama U; Sureshwar P
Drug Dev Ind Pharm; 2009 Feb; 35(2):252-8. PubMed ID: 18798090
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.
Sahoo J; Murthy PN; Biswal S; Sahoo SK; Mahapatra AK
AAPS PharmSciTech; 2008; 9(2):577-82. PubMed ID: 18459050
[TBL] [Abstract][Full Text] [Related]
26. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
Jadiya S; Upmanyu N; Sathiyanarayanan A; Jain V; Dubey R; Buwade P
J Pharm Sci; 2024 Jul; 113(7):1919-1926. PubMed ID: 38401631
[TBL] [Abstract][Full Text] [Related]
27. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
28. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
Lee BJ; Ryu SG; Cui JH
Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
[TBL] [Abstract][Full Text] [Related]
29. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
Aburahma MH; Mahmoud AA
AAPS PharmSciTech; 2011 Dec; 12(4):1335-47. PubMed ID: 21979886
[TBL] [Abstract][Full Text] [Related]
30. Variables influencing drug release from layered matrix system comprising hydroxypropyl methylcellulose.
Phaechamud T
AAPS PharmSciTech; 2008; 9(2):668-74. PubMed ID: 18500559
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
Mutalik S; Anju P; Manoj K; Usha AN
Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447
[TBL] [Abstract][Full Text] [Related]
32. Optimization of budesonide compression-coated tablets for colonic delivery.
Yehia SA; Elshafeey AH; Sayed I; Shehata AH
AAPS PharmSciTech; 2009; 10(1):147-57. PubMed ID: 19199041
[TBL] [Abstract][Full Text] [Related]
33. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
34. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
35. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
Ebube NK; Jones AB
Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
[TBL] [Abstract][Full Text] [Related]
36. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
Ige PP; Gattani SG
Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
[TBL] [Abstract][Full Text] [Related]
37. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
Khan ZA; Tripathi R; Mishra B
AAPS PharmSciTech; 2011 Dec; 12(4):1312-23. PubMed ID: 21969244
[TBL] [Abstract][Full Text] [Related]
38. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.
Piyakulawat P; Praphairaksit N; Chantarasiri N; Muangsin N
AAPS PharmSciTech; 2007 Nov; 8(4):E97. PubMed ID: 18181557
[TBL] [Abstract][Full Text] [Related]
39. Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya--chitosan polyelectrolyte complexes.
Lankalapalli S; Kolapalli RM
Drug Dev Ind Pharm; 2012 Jul; 38(7):815-24. PubMed ID: 22087874
[TBL] [Abstract][Full Text] [Related]
40. Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets.
Kim JY; Lee SH; Park CW; Rhee YS; Kim DW; Park J; Lee M; Seo JW; Park ES
Drug Des Devel Ther; 2015; 9():695-706. PubMed ID: 25678774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]